{"id":8490,"date":"2022-10-20T04:39:51","date_gmt":"2022-10-20T04:39:51","guid":{"rendered":"https:\/\/europeanvenousforum.org\/?page_id=8490"},"modified":"2022-10-20T04:39:51","modified_gmt":"2022-10-20T04:39:51","slug":"22nd-evf-scientific-programme","status":"publish","type":"page","link":"https:\/\/europeanvenousforum.org\/index.php\/22nd-evf-scientific-programme\/","title":{"rendered":"22nd EVF Scientific Programme"},"content":{"rendered":"<ul>\n<li style=\"text-align: center;\"><span style=\"color: #808080;\">22nd annual Meeting of the European Venous Forum<\/span><\/li>\n<li style=\"text-align: center;\"><span style=\"color: #808080;\">30 June &#8211; 2 July 2022<\/span><\/li>\n<\/ul>\n<h1 style=\"text-align: center;\"><span style=\"color: #003366;\">Provisional Scientific Programme<\/span><\/h1>\n<p>&nbsp;<\/p>\n<p style=\"text-align: center;\"><span style=\"color: #808080;\">Please<\/span>&nbsp;<a href=\"mailto:evf@womblab.com\" target=\"_blank\" rel=\"noopener\">contact Womblab&nbsp;srl<\/a> <span style=\"color: #808080;\">with any registration queries.&nbsp;Womblab are acting on behalf of the EVF<\/span><\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: center;\"><a href=\"https:\/\/europeanvenousforum.org\/wp-content\/uploads\/2022\/07\/EVF-2022-online-HighRes_compressed.pdf\" target=\"_blank\" rel=\"noopener\"><em><strong>Download the Programme\/Book of Abstracts<\/strong><\/em><\/a><\/p>\n<p>&nbsp;<\/p>\n<h3 style=\"text-align: center;\"><span style=\"color: #003366;\">THURSDAY 30 JUNE 2022<\/span><\/h3>\n<table width=\"704\">\n<tbody>\n<tr>\n<td width=\"128\"><span style=\"color: #808080;\">08.00-08.30<\/span><\/td>\n<td width=\"576\"><span style=\"color: #808080;\"><strong>Industry Video Session<\/strong><strong>: <\/strong>(5 minute presentation, 5 minute discussion) 3 presentations<\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Chair: Marzia Lugli<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"128\"><span style=\"color: #808080;\">08.30-10.30<\/span><\/td>\n<td width=\"576\"><span style=\"color: #003366;\"><strong>Abstract Session 1: Venous Thromboembolism<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\">(10 minute presentation, 10 minute discussion)<\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Chairs: Oscar Maleti, Andrew Nicolaides<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"128\"><span style=\"color: #808080;\">08.30-08.50 1.1<\/span><\/td>\n<td width=\"576\"><span style=\"color: #808080;\"><strong>Predictive value of cellular indices for adverse outcomes in VTE patients. Study from RIETE (Registro Informatizado Enfermedad tromboembolica) Registry.<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Fakiha Siddiqui*<sup>1<\/sup>; Alfonso Tafur<sup>2<\/sup>; Mushtaq Hussain<sup>3<\/sup>; Alberto Garc\u00eda-Orteg<sup>4<\/sup>; Pablo Demelo-Rodr\u00edgu<sup>5<\/sup>; Jos\u00e9 Antonio Nieto<sup>6<\/sup>; Esther Usandizaga<sup>7<\/sup>; Jawed Fareed<sup>8<\/sup>; Manuel Monreal<sup>9<\/sup><\/em><\/span><\/p>\n<p><span style=\"color: #808080;\"><em><sup>1<\/sup><\/em><em>Loyola University Chicago, Maywood, USA; <sup>2<\/sup>NorthShore University Health Systems, Skokie, USA; <sup>3<\/sup>Dow University of Health Sciences, Karachi, Pakistan; <sup>4<\/sup>Hospital Universitari i Polit\u00e8cnic La Fe, Valencia, Spain; <sup>5<\/sup>Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain; <sup>6<\/sup>Hospital General Virgen de la Luz, Cuenca, Spain; <sup>7<\/sup>Hospital Sant Joan Desp\u00ed-Moises Broggi, Barcelona, Spain; <sup>8<\/sup>Cardiovascular Research Institute, Loyola University Chicago,, Maywood, USA; <sup>9<\/sup>Hospital Universitari Germans Trias i Pujol., Barcelona, Spain<\/em><\/span><\/p>\n<p><span style=\"color: #808080;\"><strong><em>Submitted for the EVF Prize<\/em><\/strong><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"128\"><span style=\"color: #808080;\">08.50-09.10 1.2<\/span><\/td>\n<td width=\"576\"><span style=\"color: #808080;\"><strong>Treating acute, subacute, and chronic deep vein thrombosis using mechanical thrombectomy: Six-month outcomes from The United States CLOUT Registry.<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Nicolas Mouawad*. McLaren Health System, Bay City, USA<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"128\"><span style=\"color: #808080;\">09.10-09.30 1.3<\/span><\/td>\n<td width=\"576\"><span style=\"color: #808080;\"><strong>High incidence of thrombosis in patients with severe covid19 infection: LMWH at intermediate doses does not reduce the risk of thrombosis but is associated with lower mortality.<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Marta Camats Terr\u00e9*; Teresa Solanich Valldaura; Granada Perea Duran; Luz Mu\u00f1oz Marin; Rita Subirana Bofill; Anna Valle Beltran; Anna Artigas Soler; Kinu Reyes Kim; Anna Gasulla Rodr\u00edguez; Juan Gabriel Castro R\u00edos; Juan Carlos Oliva Morera<\/em><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Parc Taul\u00ed Hospital Universitari, Sabadell, Spain<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"128\"><span style=\"color: #808080;\">09.30-09.50 1.4<\/span><\/td>\n<td width=\"576\"><span style=\"color: #808080;\"><strong>The effects of post-thrombotic venous outflow obstruction on cardiac function during exercise.<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Rachael Morris*<sup>1<\/sup>; Bram Ruijsink<sup>1<\/sup>; Richard Bruce1; Philip Marino<sup>2<\/sup>; Bhashkar Mukherjee<sup>2<\/sup>; Aimee Brame<sup>2<\/sup>; Reza Razavi<sup>1<\/sup>; Alberto Smith<sup>1<\/sup>; Stephen Black<sup>1<\/sup><\/em><\/span><\/p>\n<p><span style=\"color: #808080;\"><em><sup>1<\/sup><\/em><em>Kings College London, London, UK; <sup>2<\/sup>St Thomas&#8217; Hospital, London, UK<\/em><\/span><\/p>\n<p><span style=\"color: #808080;\"><strong><em>Submitted for the EVF Prize<\/em><\/strong><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"128\"><span style=\"color: #808080;\">09.50-10.10 1.5<\/span><\/p>\n<p><span style=\"color: #808080;\"><strong>VIRTUAL<\/strong><\/span><\/td>\n<td width=\"576\"><span style=\"color: #808080;\"><strong>Long-term results of tinzaparin for the treatment of superficial vein thrombosis of the lower limbs.<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Chrysanthi Papageorgopoulou*; Konstantinos Nikolakopoulos; Spyros Papadoulas; Stavros Kakkos. University Hospital of Patras, Patras, Greece<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"128\"><span style=\"color: #808080;\">10.10-10.30 1.6<\/span><\/td>\n<td width=\"576\"><span style=\"color: #808080;\"><strong>Development of an international standard set of outcome measures for patients with venous thromboembolism: A Report of The International Consortium For Health Outcomes Measurement (ICHOM) Venous Thromboembolism Working Group.<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Adam Gwozdz*<sup>1<\/sup>; Cindy de Jong<sup>2<\/sup>; Luz Fialho3; Frieda Sossi<sup>3<\/sup>; Theerawich Likitabhorn<sup>4<\/sup>; Stephen Black<sup>1<\/sup>; Frederikus Klok<sup>2<\/sup>. <sup>1<\/sup>Academic Department of Vascular Surgery, School of Cardiovascular Medicine and Science, King&#8217;s Colle, London, UK; 2Department of Medicine, Thrombosis and Haemostasis, Leiden University Medical Center, Leiden, Netherlands; <sup>3<\/sup>International Consortium for Health Outcomes Measurement, London, UK; <sup>4<\/sup>International Consortium for Health Outcomes Measurement, Boston, USA<\/em><\/span><\/p>\n<p><span style=\"color: #808080;\"><strong><em>Submitted for the EVF Prize<\/em><\/strong><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"128\"><span style=\"color: #808080;\">10.30-11.00<\/span><\/td>\n<td width=\"576\"><span style=\"color: #808080;\">Refreshments | View ePoster Presentations | Visit Exhibition<\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"128\"><span style=\"color: #808080;\">11.00-13.00<\/span><\/td>\n<td width=\"576\"><span style=\"color: #003366;\"><strong>Abstract Session 2: Venous Thromboembolism<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><strong>&nbsp;<\/strong>(10 minute presentation, 10 minute discussion)<\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Chairs: Stavros Kakkos, Raffaele Pesavento<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"128\"><span style=\"color: #808080;\">11.00-11.20 2.1<\/span><\/td>\n<td width=\"576\"><span style=\"color: #808080;\"><strong>Sulodexide as a complimentary drug on the management of acute deep venous thrombosis.<\/strong><\/span><\/p>\n<p><em><span style=\"color: #808080;\">Erasto Aldrett Lee*<sup>1<\/sup>; Nora Enid Lecuona Huet<sup>2<\/sup><\/span><\/em><\/p>\n<p><span style=\"color: #808080;\"><em><sup>1<\/sup><\/em><em>Hospital Lomas de San Luis, San Luis Potos\u00ed, Mexico; <sup>2<\/sup>Hospital Lomas de San Luis, Mexico City, Mexico<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"128\"><span style=\"color: #808080;\">11.20-11.40 2.2<\/span><\/p>\n<p><span style=\"color: #808080;\"><strong>VIRTUAL<\/strong><\/span><\/td>\n<td width=\"576\"><span style=\"color: #808080;\"><strong>Implementation of a direct oral anticoagulant perioperative interruption protocol and accuracy of the DOAC urine dipstick.<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Guillermo Tafur*<sup>1<\/sup>; Luis Paz Rios<sup>2<\/sup>; Thomas Gniadek<sup>3<\/sup>; Jeanine Walenga<sup>4<\/sup>; Jawed Fareed<sup>4<\/sup>; Marisa Durante<sup>3<\/sup>; Job Harenberg<sup>5<\/sup>; Alfonso Tafur<sup>3<\/sup><\/em><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>1Northwestern University, Evanston, USA; 2Massachusetts General Hospital, Boston, USA; 3NorthShore University Health System, Evanston, USA; 4Loyola University Medical Center, Maywood, USA; 5DOASENSE GmbH, Heidelberg University, Heidelberg, Germany<\/em><\/span><\/p>\n<p><span style=\"color: #808080;\"><strong><em>Submitted for the EVF Prize<\/em><\/strong><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"128\"><span style=\"color: #808080;\">11.40-12.00 2.3<\/span><\/td>\n<td width=\"576\"><span style=\"color: #808080;\"><strong>Readability of patient educational materials in venous thrombosis. Analysis of the 2021 ESVS guidelines and comparison with other medical societies information.<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Enrique San Norberto*<sup>1<\/sup>; \u00c1lvaro Revilla<sup>1<\/sup>; Jos\u00e9-Antonio Brizuela<sup>1<\/sup>; Manuel Diez<sup>1<\/sup>; James Taylor<sup>2<\/sup>; Carlos Vaquero<sup>1<\/sup>. 1Valladolid University Hospital, Valladolid, Spain; 2Valencia General University Hospital, Valencia, Spain<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"128\"><span style=\"color: #808080;\">12.00-12.20 2.4<\/span><\/td>\n<td width=\"576\"><span style=\"color: #808080;\"><strong>Predictive Role Of Blood Cellular Indices And Endogenous Glycosaminoglycans As Determinants Of Inflammatory Biomarkers In Acute Pulmonary Embolism.<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Fakiha Siddiqui*; <\/em><em>Bulent Kantarcioglu*; Amir Darki; Joseph Lewis; Trent Reed; Omer Iqbal; Walter Jeske; Jawed Fareed<\/em><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Loyola University Chicago, Chicago, USA<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"128\"><span style=\"color: #808080;\">12.20-12.40 2.5<\/span><\/td>\n<td width=\"576\"><span style=\"color: #808080;\"><strong>Systematic review and meta-analysis of venous thromboembolism prophylaxis after endovenous varicose vein surgery.<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Benedict Turner*; Matthew Machin; Sara Jasionowska; Alun H Davies<\/em><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Charing Cross Hospital, Imperial College London, London, UK<\/em><\/span><\/p>\n<p><span style=\"color: #808080;\"><strong><em>Submitted for the EVF Prize<\/em><\/strong><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"128\"><span style=\"color: #808080;\">12.40-13.00 2.6<\/span><\/td>\n<td width=\"576\"><span style=\"color: #808080;\"><strong>Impact of standard catheter directed thrombolysis versus ultrasound assisted thrombolysis on total or subtotal pulmonary arterial occlusions in patients with pulmonary embolism. A secondary analysis of the SUNSET Trial.<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Efthymios Avgerinos*<sup>1<\/sup>; Elizabeth Andraska<sup>1<\/sup>; Riyaz Bashir<sup>2<\/sup>; Wisam Jaber<sup>3<\/sup>; Joan Lacomis<sup>1<\/sup>; Michael McDaniel<sup>3<\/sup>; Charles Ross<sup>4<\/sup>; Rabih Chaer<sup>1<\/sup>. <\/em><\/span><\/p>\n<p><span style=\"color: #808080;\"><em><sup>1<\/sup><\/em><em>University of Pittsburgh Medical Center, Pittsburgh, USA; <sup>2<\/sup>Division of Cardiovascular Disease, Lewis Katz School of Medicine at Temple University, Philadelphia, USA; <sup>3<\/sup>Emory University, Atlanta, USA; <sup>4<\/sup>Piedmont Heart Center, Atlanta, USA<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"128\"><span style=\"color: #808080;\">13.00-14.00<\/span><\/td>\n<td width=\"576\"><span style=\"color: #808080;\"><strong>View ePoster Presentations <\/strong>(4 minute presentations)<\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Chair: Andrew Nicolaides, Erika Mendoza, Efthymios Avgerinos, Attilo Cavezzi<\/em><\/span><\/p>\n<p><a href=\"https:\/\/europeanvenousforum.org\/index.php\/eposter-programme\/\">See separate page for programme<\/a><\/td>\n<\/tr>\n<tr>\n<td width=\"128\"><span style=\"color: #808080;\">13.00-14.00<\/span><\/td>\n<td width=\"576\"><span style=\"color: #808080;\">Lunch | Visit Exhibition<\/span><\/td>\n<\/tr>\n<tr>\n<td rowspan=\"3\" width=\"128\"><span style=\"color: #808080;\">13.15-14.00<\/span><\/td>\n<td width=\"576\"><span style=\"color: #808080;\"><strong>\u201cMeet the Experts\u201d Session<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Chairs: Efthymios Avgerinos, <\/em><em>Domenico Baccellieri <\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"576\"><span style=\"color: #808080;\"><strong>Iliac stenting: how I do it.<\/strong> <em>Stephen Black (UK)<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"576\"><span style=\"color: #808080;\"><strong>Thermal vs Non-thermal ablation: when and how I do it.<\/strong> <em>Manjit Gohel (UK)<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"128\"><span style=\"color: #808080;\">14.00-15.00<\/span><\/td>\n<td width=\"576\"><strong><a href=\"https:\/\/europeanvenousforum.org\/index.php\/evf-meeting\/scientific-programme\/industry-sponsored-symposia\/\">Industry Session 1<\/a><\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"128\"><span style=\"color: #808080;\">15.00-16.00<\/span><\/td>\n<td width=\"576\"><span style=\"color: #808080;\"><strong>Didactic Session 1: Advances in the management of acute DVT<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Chairs: Niels Baekgaard, A Ierardi<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"128\"><span style=\"color: #808080;\">15.00-15.15<\/span><\/p>\n<p><span style=\"color: #808080;\"><strong>VIRTUAL<\/strong><\/span><\/td>\n<td width=\"576\"><span style=\"color: #808080;\"><strong>Early Thrombus Removal: who, when and how.<\/strong> <em>Gerard O\u2019Sullivan (Ireland)<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"128\"><span style=\"color: #808080;\">15.15-15.30<\/span><\/td>\n<td width=\"576\"><span style=\"color: #808080;\"><strong>Acute DVT complicating MT syndrome.<\/strong> <em>Michael Lichtenberg (Germany)<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"128\"><span style=\"color: #808080;\">15.30-15.45<\/span><\/td>\n<td width=\"576\"><span style=\"color: #808080;\"><strong>Why to be aggressive in young patient affected by DVT.<\/strong> <em>Marzia Lugli (Italy)<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"128\"><span style=\"color: #808080;\">15.45-16.00<\/span><\/td>\n<td width=\"576\"><span style=\"color: #808080;\"><strong>Which compression in acute DVT and how to apply.<\/strong> <em>Giovanni Mosti (Italy)<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"128\"><span style=\"color: #808080;\">16.00-16.30<\/span><\/td>\n<td width=\"576\"><span style=\"color: #808080;\">Refreshments | Visit Exhibition | <\/span><span style=\"color: #808080;\">View ePoster Presentations<\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"128\"><span style=\"color: #808080;\">16.30-17.30<\/span><\/td>\n<td width=\"576\"><span style=\"color: #808080;\"><strong>Didactic Session 2: Advances in the management of chronic venous insufficiency<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Chairs: Athanasios Giannoukas, <\/em><em>Giovanni Agus<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"128\"><span style=\"color: #808080;\">16.30-16.45<\/span><\/td>\n<td width=\"576\"><span style=\"color: #808080;\"><strong>Hypodermitis, skin inflammation: how to treat.<\/strong> <em>Lourdes Reina Gutierrez (Spain)<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"128\"><span style=\"color: #808080;\">16.45-17.00<\/span><\/td>\n<td width=\"576\"><span style=\"color: #808080;\"><strong>How to measure PTS disease and outcomes after operative treatments.<\/strong> <em>Sabina Villalta (Italy)<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"128\"><span style=\"color: #808080;\">17.00-17.15<\/span><\/td>\n<td width=\"576\"><span style=\"color: #808080;\"><strong>Which pharmacological therapy after stenting.<\/strong> <em>Mario Bazzan (Italy)<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"128\"><span style=\"color: #808080;\">17.15-17.30<\/span><\/td>\n<td width=\"576\"><span style=\"color: #808080;\"><strong>Chronic venous disease and diabetic microangiopathy: pathophysiology and commonalities.<\/strong> <em>Marie Josee van Rijn (Netherlands)<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"128\"><span style=\"color: #808080;\">17.30-18.30<\/span><\/td>\n<td width=\"576\"><strong><a href=\"https:\/\/europeanvenousforum.org\/index.php\/evf-meeting\/scientific-programme\/industry-sponsored-symposia\/\">Industry Session 2<\/a><\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>&nbsp;<\/strong><\/p>\n<h3 style=\"text-align: center;\"><span style=\"color: #003366;\">FRIDAY 1 JULY 2022<\/span><\/h3>\n<table width=\"699\">\n<tbody>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">08.00-08.30<\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\"><strong>Industry Video Session<\/strong><strong>: <\/strong>(5 minute presentation, 5 minute discussion) 3 presentations<\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Chair: Giovanni Lipari (Italy)<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">08.30-10.30<\/span><\/td>\n<td width=\"568\"><span style=\"color: #003366;\"><strong>Abstract Session 3: Iliac occlusion and pelvic congestion syndrome, Cyanoacrylate, Epidemiology<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><strong>&nbsp;<\/strong>(10 minute presentation, 10 minute discussion)<\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Chairs: Dominik Heim, Gennaro Quarto <\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">08.30-08.50 3.1<\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\"><strong>Patency rates and predictors for re-intervention after stenting for acute or chronic deep vein thrombosis: a retrospective observational study<\/strong>.<\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Jay M. Bakas*; Adriaan Moelker; Catherine van Montfrans; Marie Josee E. van Rijn<\/em><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Erasmus Medical Center, Rotterdam, Netherlands<\/em><\/span><\/p>\n<p><span style=\"color: #808080;\"><strong><em>Submitted for the EVF Prize<\/em><\/strong><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">08.50-09.10 3.2<\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\"><strong>Identification of patients with outflow obstruction most likely to benefit from iliac stenting.<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Fedor Lurie*. Jobst Vascular Institute, Toledo, USA<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">09.10-09.30 3.3<\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\"><strong>Hybrid ilio-femoral recanalization after injection for drug abuse obstruction: a single centre experience.<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Elisa Munari*; Marzia Lugli; Matteo Longhi; Oscar Maleti. Hesperia Hospital, Modena, Italy<\/em><\/span><\/p>\n<p><span style=\"color: #808080;\"><strong><em>Submitted for the EVF Prize<\/em><\/strong><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">09.30-09.50 3.4<\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\"><strong>Endovascular treatment of pelvic congestive syndrome, literature review. Is pharmacomechanical ablation of gonadal veins an alternative to classic embolization?<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Eliseo Candela Beltran*. Hospital de Manises, Valencia, Spain<\/em><\/span><\/p>\n<p><span style=\"color: #808080;\"><strong><em>Submitted for the EVF Prize<\/em><\/strong><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">09.50-10.10 3.5<\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\"><strong>Evolution of the epidemiology and management of chronic venous disease in the UK.<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Safa Salim*<sup>1<\/sup>; Mahsa Mazidi<sup>1<\/sup>; Roberto Fernandez Crespo<sup>1<\/sup>; Estelle Collin<sup>2<\/sup>; Sarah Onida<sup>1<\/sup>; Joanna Chirol<sup>2<\/sup>; Alun H Davies<sup>1<\/sup>. <sup>1<\/sup>Imperial College London, London, UK; <sup>2<\/sup>Servier, Paris, France<\/em><\/span><\/p>\n<p><span style=\"color: #808080;\"><strong><em>Submitted for the EVF Prize<\/em><\/strong><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">10.10-10.30 3.6<\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\"><strong>Correlation Amongst Transvaginal And Transabdominal Duplex And CT Angiogram For Pelvic Venous Insufficiency And Leg Varicosities<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Lourdes Reina Gutierrez*<sup>1<\/sup>; Angel Sanchez Guerrero<sup>2<\/sup>; Luis Albeniz<sup>1<\/sup>; Jose Ignacio Fernandez Solares<sup>1<\/sup>; Agnieszka Nowak Tarnawska<sup>1<\/sup>; Carlos Barrio Rodriguez<sup>1<\/sup>; Angela Miguel Morrondo<sup>1<\/sup>; Aurora Florez-Gonzalez<sup>1<\/sup>; Alfonso Sanjuanbenito-Reina<sup>3<\/sup>; Jose Antonio Gonzalez-Fajardo<sup>2<\/sup>; <\/em><\/span><\/p>\n<p><span style=\"color: #808080;\"><em><sup>1<\/sup><\/em><em>Hospital Central de la Cruz Roja, Madrid, Spain; <sup>2<\/sup>Hospital Universitario 12 de Octubre, Madrid, Spain; <sup>3<\/sup>Universidad Autonoma, Madrid, Spain<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">10.30-11.00<\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\">Refreshments | View ePoster Presentations | Visit Exhibition<\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">11.00-12.00<\/span><\/td>\n<td width=\"568\"><strong><a href=\"https:\/\/europeanvenousforum.org\/index.php\/evf-meeting\/scientific-programme\/industry-sponsored-symposia\/\">Industry Session 3<\/a><\/strong><\/td>\n<\/tr>\n<tr>\n<td rowspan=\"2\" width=\"131\"><span style=\"color: #808080;\">12.00-12.30<\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\"><strong>EVF Invited Lecture <\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Chair: Oscar Maleti (Italy)<\/em><\/span><\/p>\n<p><span style=\"color: #808080;\">Introduction by Oscar Maleti<\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"568\"><span style=\"color: #808080;\"><strong>COVID-19 and Thrombosis: basis and management of an incendiary duality.<\/strong> <em>Ismail Elalamy (France)<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">12.30-13.00<\/span><\/td>\n<td width=\"568\"><span style=\"color: #003366;\"><strong>Didactic Session 3: Guidelines of Chronic Venous Disease<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Chairs: Tomasz Urbanek, Gaetano Lanza<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">12.30-12.45<\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\"><strong>Comparison of recent guidelines for Chronic Venous Disease.<\/strong> <em>Dominik Heim&nbsp;(Switzerland)<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">12.45-13.00<\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\"><strong>What is not in the Guidelines<\/strong><em><strong>.<\/strong> Imre Bihari (Hungary)<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">13.00-14.00<\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\"><strong>Refreshments | <\/strong><\/span><span style=\"color: #808080;\"><strong>View ePoster Presentations <\/strong>(4 minute presentations)<\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Chairs: Andrew Nicolaides, Erika Mendoza, Efthymios Avgerinos, Attilo Cavezzi<\/em> <\/span><\/p>\n<p><a href=\"https:\/\/europeanvenousforum.org\/index.php\/eposter-programme\/\">See separate page for programme<\/a><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">13.15-14.00<\/span><\/td>\n<td width=\"568\"><strong><a href=\"https:\/\/europeanvenousforum.org\/index.php\/evf-meeting\/scientific-programme\/industry-sponsored-symposia\/\">Industry Workshop<\/a><\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">13.00-14.00<\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\">Visit Exhibition<\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">14.00-15.00<\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\"><strong>EVF Annual General Meeting (Members Only)<\/strong><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">15.00-16.00<\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\"><strong>Joint EVF\/AVF Session Debate: <\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Chairs: Marianne Vandendriessche, Lugli Marzia<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">15.00-15.30<\/span><\/td>\n<td width=\"568\"><strong><span style=\"color: #808080;\">Evaluation of patients with CVI should include pelvic venous imaging in addition to lower extremity imaging.<\/span><\/strong><\/p>\n<p><span style=\"color: #808080;\"><em>For: Kathleen Ozsvath (USA), AVF | Against: Armando Mansilha (Portugal) EVF<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">15.30-16.00<\/span><\/p>\n<p><span style=\"color: #808080;\"><strong>VIRTUAL<\/strong><\/span><\/td>\n<td width=\"568\"><strong><span style=\"color: #808080;\">Venoactive drugs are useful in the management of patients with chronic venous disease in all stages of CEAP.<\/span><\/strong><\/p>\n<p><span style=\"color: #808080;\"><em>For: Andrew Nicolaides, EVF | Against: Nicos Labropoulos (AVF)<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">16.00-16.30<\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\">Refreshments| Visit ePoster Presentations | Visit Exhibition<\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">16.30-17.30<\/span><\/td>\n<td width=\"568\"><strong><a href=\"https:\/\/europeanvenousforum.org\/index.php\/evf-meeting\/scientific-programme\/industry-sponsored-symposia\/\">Industry Session 4<\/a><\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">17.30-18.30<\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\"><strong>Prize winning papers from the Japanese Society of Phlebology, American Venous Form and American Vein and Lymphatic Society<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\">(10 minute presentation, 10 minute discussion)<\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Chairs: Erika Mendoza, Angelo Santoliquido<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">17.30<\/span><\/p>\n<p><span style=\"color: #808080;\"><strong>VIRTUAL<\/strong><\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\"><strong>Incidence and Clinical Features of Venous Thromboembolism in Hospitalized Patients with COVID-19 in Japan<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Yugo Yamashita<\/em><em>: Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan<\/em><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Norikazu Yamada: Department of Cardiology, Kuwana City Medical Center, Kuwana, Japan<\/em><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Mo Makoto: Department of Cardiovascular Surgery, Yokohama Minami Kyosai Hospital, Kanagawa, Japan<\/em><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>JSP Prize paper<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">17.50<\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\"><strong>Is Oedema Underrecognized in Superficial Venous Disease Patients?<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Sophia C. Weldon, Christopher Pittman, Stachyse Stanis, Anna M. Wright.<\/em><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Vein911 Vein Treatment Centers, Tampa, Florida, USA<\/em><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>AVLS Prize Paper<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">18.10<\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\"><strong>Markers of pulmonary hypertension in patients with submassive pulmonary embolism undergoing catheter thrombolysis compared to anticoagulation alone: a secondary analysis of the SUNSET sPE trial.<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Andraska EA<sup>1<\/sup>, Bonaroti J<sup>2<\/sup>, Zhang Y<sup>3<\/sup>, Rivera-Lebron B<sup>3<\/sup>, Chaer RA<sup>1<\/sup>, Avgerinos ED<sup>1<\/sup>&nbsp;<\/em><\/span><\/p>\n<p><span style=\"color: #808080;\"><em><sup>1<\/sup><\/em><em>UPMC, Department of Surgery, Division of Vascular Surgery; Pittsburgh, Pennsylvania, United States <\/em><\/span><\/p>\n<p><span style=\"color: #808080;\"><em><sup>2<\/sup><\/em><em>UPMC, Department of Surgery;&nbsp;Pittsburgh, Pennsylvania, USA <\/em><\/span><\/p>\n<p><span style=\"color: #808080;\"><em><sup>3<\/sup><\/em><em>UPMC, Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine;&nbsp;Pittsburgh, Pennsylvania, USA<\/em><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>AVF Prize paper<\/em><\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<h3 style=\"text-align: center;\"><span style=\"color: #003366;\">SATURDAY 2 JULY 2022<\/span><\/h3>\n<table width=\"699\">\n<tbody>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">08.30-10.30<\/span><\/td>\n<td width=\"568\"><span style=\"color: #003366;\"><strong>Abstract Session 4: Compression, microcirculation, telangiectasia, varicose veins<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\">(10 minute presentation, 10 minute discussion)<\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Chairs: Imre Bihari, Marco Viani<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">08.30-08.50 4.1<\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\"><strong>A randomized trial of moderate (class 2), high (class 3) and very high (class 4) elastic compression in the prevention of recurrence of venous ulceration. <\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Dragan Milic*<sup>1<\/sup>; Sasa Zivic<sup>2<\/sup>; Milan Lazarevic<sup>1<\/sup>; Dragan Bogdanovic<sup>3<\/sup>; Bekim Ademi<sup>4<\/sup>; Isidora Milic<sup>5<\/sup>. <sup>1<\/sup>University Clinical Centre Nis, Medical school University of Nis, Nis, Serbia; <sup>2<\/sup>University Clinical Centre Nis, Nis, Serbia; <sup>3<\/sup>University of Novi Pazar, Novi Pazar, Serbia; <sup>4<\/sup>Clinical Centre Pristina, Kosovo*, Presevo, Serbia; <sup>5<\/sup>Medical school University of Nis, Nis, Serbia<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">08.50-09.10 4.2<\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\"><strong>COmpressioN Following Endovenous TreatmenT of Incompetent Varicose Veins (CONFETTI).<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>A Belramman*; R Bootun; TRA Lane; CV Riga; C Aylwin; J Shalhoub; U Jaffer; C Bicknell; AH Davies. <\/em><\/span><span style=\"color: #808080;\"><em>Imperial College London, London, UK<\/em><\/span><\/p>\n<p><span style=\"color: #808080;\"><strong>Submitted for the EVF Prize<\/strong><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">09.10-09.30 4.3<\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\"><strong>Microcirculatory alterations in chronic venous disorder &#8212; Observation in C0s patients (CEAP Classification).<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Eliete Bouskela*<sup>1<\/sup>; Bernardo Cunha Senra Barros<sup>2<\/sup>; Carlos Eduardo Virgini Magalh\u00e3es<sup>1<\/sup>; Daniel Alexandre Bottino<sup>1<\/sup>. <sup>1<\/sup>State University of Rio de Janeiro, Rio de Janeiro, Brazil; <sup>2<\/sup>Federal University of Rio de Janeiro State, Rio de Janeiro, Brazil<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">09.30-09.50 4.4<\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\"><strong>Prevalence of chronic venous disease in primary care centers in Azerbaijan: The VEINSCOPE Study.<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Farhad Aghayev*. <\/em><\/span><span style=\"color: #808080;\"><em>Baku Phlebological Center, Baku, Azerbadijan<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">09.50-10.10 4.5<\/span><\/p>\n<p><span style=\"color: #808080;\"><strong>VIRTUAL<\/strong><\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\"><strong>Frequency of postoperative neuropathies after phlebectomy and minimal invasive treatment methods for varicose veins<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Anna \u016adre*<sup>1<\/sup>; Solvita B\u0113rzi\u0146a<sup>2<\/sup>; Patricija Ivanova<sup>3<\/sup>; Ints \u016adris<sup>3 <\/sup><\/em><\/span><span style=\"color: #808080;\"><em><sup>1<\/sup><\/em><em>Riga East Clinical University Hospital, University of Latvia, Riga, Latvia; <sup>2<\/sup>Riga East Clinical University Hospital, Riga, Latvia; <sup>3<\/sup>Riga East Clinical University Hospital, Baltic Vein Clinic, University of Latvia, Riga, Latvia<\/em><\/span><br \/>\n<span style=\"color: #808080;\"><strong><em>Submitted for the EVF Prize<\/em><\/strong><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">10.10-10.30 4.6<\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\"><strong>N-butyl-2-cyanoacrylate glue ablation as a single-catheter procedure for the great saphenous vein insufficiency treatment &#8211; 5-years follow-up.<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Michal Juszynski*; Jan Wawszczak; Grzegorz Madycki. Centre of Postgraduate Medical Education, Warsaw, Poland<\/em><\/span><\/p>\n<p><span style=\"color: #808080;\"><strong><em>Submitted for the EVF Prize<\/em><\/strong><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">10.30-11.00<\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\">View ePoster Presentations and visit Exhibition<\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">11.00-13.00<\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\"><strong>Abstract Session 5: Congenital malformation, lymphatics, complications of thrombolysis, obesity, AI Guidance<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\">(10 minute presentation, 10 minute discussion)<\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Chairs: Armando Mansilha, Francesco Stillo<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">11.00-11.20 5.1<\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\"><strong>Remote expert DVT triaging of novice-user compression sonography with AI guidance.<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Jonas Oppenheimer<sup>1<\/sup>; Ramin Mandegaran<sup>2<\/sup>; Sven Mischkewitz<sup>1<\/sup>; Fouad Al Noor<sup>3<\/sup>; Andrea Adler<sup>4<\/sup>; Stephan Sing\u00f6hl<sup>4<\/sup>; Mattias Heinrich<sup>5<\/sup>; Bernhard Kainz<sup>6<\/sup>; Stavros Spiliopoulos<sup>7<\/sup>; George Geroulakos<sup>7<\/sup>; Efthymios Avgerinos*<sup>7<\/sup><\/em><\/span><\/p>\n<p><span style=\"color: #808080;\"><em><sup>1<\/sup><\/em><em>ThinkSono GmbH, Potsdam, Germany; <sup>2<\/sup>Central Alberta Medical Imaging Services, Red Deer, Canada; <sup>3<\/sup>ThinkSono GmbH, London, UK; <sup>4<\/sup>Klinikum Magdeburg, Magdeburg, Germany; <sup>5<\/sup>University of L\u00fcbeck, L\u00fcbeck, Germany; <sup>6<\/sup>FAU Erlangen-N\u00fcrnberg, Erlangen, Germany; <sup>7<\/sup>Attikon University Hospital, National and Kapodistrian University of Athens, Athens, Greece<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">11.20-11.40 5.2<\/span><\/p>\n<p>&nbsp;<\/td>\n<td width=\"568\"><span style=\"color: #808080;\"><strong>Benefit of an adjustable compression system for the reduction of oedema (akro study)- preliminary results.<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Gabriele Faerber*<sup>1<\/sup>; Birgit Kahle<sup>2<\/sup>; Tobias Hirsch<sup>3<\/sup>; Andrzej Szuba<sup>4<\/sup><\/em><\/span><\/p>\n<p><span style=\"color: #808080;\"><em><sup>1<\/sup><\/em><em>Zentrum f\u00fcr Gef\u00e4\u00dfmedizin, Hamburg, Hamburg, Germany; <sup>2<\/sup>Universit\u00e4ts-Klinikum Schleswig-Holstein Campus Lu\u0308beck, Luebeck, Germany; <sup>3<\/sup>Praxis f\u00fcr Innere Medizin und GEfaesskrankheiten, Halle, Germany; <sup>4<\/sup>Uniwersytecki Szpital Kliniczny im.Jana Mikulicza-Radeckiego we Wroc\u0142awiu, Wroclav, Poland<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">11.40-12.00 5.3<\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\"><strong>Effect of ruscus extract, hesperidin methyl chalcone and vitamin C on human lymphatic smooth muscle cells contraction.<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Nicolas Monjotin*<sup>1<\/sup>; Guillaume Tenca<sup>2&nbsp; <\/sup><\/em><\/span><span style=\"color: #808080;\"><em><sup>1<\/sup><\/em><em>Castres, France; <sup>2<\/sup>QIMA Life Sciences, Gencay, France<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">12.00-12.20 5.4<\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\"><strong>Peri-operative management of anticoagulation and bleeding in patients undergoing CDT for acute iliofemoral DVT.<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Katherine Creeper*; Katie White; Stephen Black; Narayanan Thulasidasan; Karen Breen. Guy&#8217;s and St Thomas&#8217; NHS Foundation Trust, London, UK<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">12.20-12.40 5.5<\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\"><strong>A Systematic Review Of Compression Following Treatment Of Superficial Venous Incompetence<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Abduraheem Mohamed<sup>1<\/sup>; Sundus Mohamed*<sup>2<\/sup>; Simran Thadani<sup>3<\/sup>; Misha Sidapra<sup>1<\/sup>; George Smith<sup>1<\/sup>; Ian Chetter<sup>1<\/sup>; Daniel Carradice<sup>1<\/sup><\/em><\/span><\/p>\n<p><span style=\"color: #808080;\"><em><sup>1<\/sup><\/em><em>Hull University Teaching Hospitals, Hull, UK; <sup>2<\/sup>Leeds University Teaching Hospitals, Leeds, UK; <sup>3<\/sup>Hull York Medical School, Hull, UK<\/em><\/span><\/p>\n<p><em><span style=\"color: #808080;\"><strong>Submitted for the EVF Prize<\/strong><\/span><\/em><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">12.40-13.00 5.6<\/span><\/p>\n<p>&nbsp;<\/td>\n<td width=\"568\"><span style=\"color: #808080;\"><strong>Stenting Of Non-thrombotic Iliac Vein Lesions: Long-term Patency Rate<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Matteo Longhi*; Marzia Lugli; Elisa Munari; Oscar Maleti. <\/em><\/span><span style=\"color: #808080;\"><em>Hesperia Hospital, Modena, Italy<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">13.00-14.00<\/span><\/td>\n<td width=\"568\"><span style=\"color: #003366;\"><strong>Didactic Session 4: Management of lymphatic disorders<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><em>Chairs: Oscar Maleti, <\/em><em>Albert Claude Benhomou<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">13.00-13.15<\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\"><strong>Quality of life after vascularised lymph node transfer or lymphovenous anastomosis in patients with lower limb lymphoedema &#8212; a systematic review.<\/strong> <em>Sarah Onida (UK)<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">13.15-13.30<\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\"><strong>Lymphoscintigraphic pattern in CEAP 0s: Role Of deep lymphatic circulation.<\/strong> <em>Alberto Maccio (Italy)<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">13.30-13.45<\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\"><strong>Role of the vein in the long-term patency of microsurgical lymphatic-venous by-pass (LVB) surgery in lymphedema treatment.<\/strong> <em>Francesco Boccardo (Italy)<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">13.45-14.00<\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\"><strong>Differential diagnosis of venous ulcer. If it is not a venous ulcer, what is it?<\/strong> <em>Daciana Branisteanu (Romania)<\/em><\/span><\/td>\n<\/tr>\n<tr>\n<td width=\"131\"><span style=\"color: #808080;\">14.00<\/span><\/td>\n<td width=\"568\"><span style=\"color: #808080;\">Presentation of EVF Prizes. <em>Oscar Maleti<\/em><\/span><\/p>\n<p><span style=\"color: #808080;\">Presentation of 2023 Meeting. <em>Erika Mendoza<\/em><\/span><\/p>\n<p><span style=\"color: #808080;\"><strong>End of meeting<\/strong><\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>22nd annual Meeting of the European Venous Forum 30 June &#8211; 2 July 2022 Provisional Scientific Programme &nbsp; Please&nbsp;contact Womblab&nbsp;srl with any registration queries.&nbsp;Womblab are acting on behalf of the EVF &nbsp; Download the Programme\/Book of Abstracts &nbsp; THURSDAY 30 JUNE 2022 08.00-08.30 Industry Video Session: (5 minute presentation, 5 \u2026 <a class=\"continue-reading-link\" href=\"https:\/\/europeanvenousforum.org\/index.php\/22nd-evf-scientific-programme\/\"> Continue reading <span class=\"meta-nav\">&rarr; <\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"templates\/template-onecolumn.php","meta":{"_exactmetrics_skip_tracking":false,"ngg_post_thumbnail":0,"footnotes":""},"class_list":["post-8490","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/europeanvenousforum.org\/index.php\/wp-json\/wp\/v2\/pages\/8490","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/europeanvenousforum.org\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/europeanvenousforum.org\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/europeanvenousforum.org\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/europeanvenousforum.org\/index.php\/wp-json\/wp\/v2\/comments?post=8490"}],"version-history":[{"count":1,"href":"https:\/\/europeanvenousforum.org\/index.php\/wp-json\/wp\/v2\/pages\/8490\/revisions"}],"predecessor-version":[{"id":8491,"href":"https:\/\/europeanvenousforum.org\/index.php\/wp-json\/wp\/v2\/pages\/8490\/revisions\/8491"}],"wp:attachment":[{"href":"https:\/\/europeanvenousforum.org\/index.php\/wp-json\/wp\/v2\/media?parent=8490"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}